BAFNA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 ,inter alia, to consider and approve A meeting of board of directors of the Company is scheduled to be held on Monday, February 12, 2024, inter-alia, to consider and approve the Un-Audited Standalone Financial Results of the Company for the third quarter of FY24 ended December 31, 2023, together with the 'Limited Review Report' for the said period.